Solid-phase transfection service

Added to bookmarks
Bookmarks list

Bookmark has been removed
Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.
Free membership registration

last updated：Mar 14, 2023

Official site

Unique technology based on the technology cultivated at the National Institute of Advanced Industrial Science and Technology!

Our company provides products and services related to solid-phase transfection. By industrializing it as a uniform and highly reproducible solid-phase plate, we have made it possible to obtain a large amount of reliable experimental data quickly and efficiently, enabling comprehensive analysis of target genes. For example, primary cultured cells are said to have superior concordance with actual clinical data compared to established cell lines. Even using these valuable and rare cellular resources, it is now possible to conduct high-efficiency and high-precision searches for target candidate molecules. 【Features】 - With the gene introduction promoter (accelerator), there are proven results for difficult-to-transfect suspension cells and primary cultured cells. - Applicable to various nucleic acids such as siRNA, miRNA, mRNA, and plasmid DNA. - Suitable for target exploration, pathway analysis, and mechanism of action analysis of compounds through large-scale screening. *For more details, please download the PDF or contact us.

Related Link - https://cytopathfinder.com/ja/

Inquire About This Product

basic information

【Lineup】 ■ Transfection Optimization Kit - Allows evaluation of numerous transfection conditions with a single plate - Solidifies nucleic acids such as your existing library siRNA or plasmid DNA under the conditions determined by the optimization kit ■ Genome Editing Plate - Achieves high transfection efficiency along with high genome editing efficiency using solid-phase methods - Suitable for creating mutant strains and knockout screening ■ siRNA Screening Using PXB-cells(R) - Achieves approximately 96% transfection efficiency using fresh human liver cells derived from chimeric mice by Phoenix Bio - Suitable for hepatitis virus infection and compound metabolism models *For more details, please download the PDF or contact us.